☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
P-III
Innovent’s IBI343 a Monotherapy Receives the NMPA’s Breakthrough Therapy Designation for Advanced Gastric Cancer (GC)
May 7, 2024
Organogenesis Reports the P-III Study Data of ReNu for Knee Osteoarthritis
May 3, 2024
Amolyt Pharma’s Eneboparatide Receives the US FDA’s Fast Track Designation for Hypoparathyroidism
May 3, 2024
AstraZeneca Reports Data from the P-III (ECHO) Study of Calquence Combination Regimen for Mantle Cell Lymphoma
May 2, 2024
Merck Reports the P-III (KEYNOTE-811) Study Data of Keytruda Plus Trastuzumab and Chemotherapy for G/GEJ Adenocarcinoma
May 2, 2024
Harmony Biosciences Expands its CNS Pipeline Through the Acquisition of Epygenix Therapeutics
May 1, 2024
Load more...
Back to Home